Participate in Arthritis Clinical Trials | Arthritis Foundation
Interested in participating in arthritis clinical trials? Learn what to expect from a clinical trial and how you can get involved.
Studies of the Natural History of Rheumatic Diseases
Dec 24, 2025 · Terms related to this study Keywords Provided by National Institutes of Health Clinical Center (CC) (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)) …
Arthritis Clinical Trials
Discover Arthritis clinical trials. Access the latest research and treatments in Arthritis care. Find clinical trials for Arthritis today!
Clinical Digest: Recent Clinical Trials on Arthritis
Apr 29, 2025 · To assist researchers and healthcare practitioners in staying up-to-date with the latest advancements in clinical research, the Clinical Digest Team has compiled a comprehensive list of …
Clinical Trials | NIAMS
Dec 9, 2024 · Information about clinical trials (research studies with people) underway to prevent and treatment arthritic and rheumatic, skin, bone, muscle, and musculoskeletal diseases and conditions, …
Clinical Trials on Rheumatoid Arthritis (RA) - ICH GCP
Rheumatoid Arthritis (RA) United States Chugai Pharma Taiwan Completed Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients …
Arthritis Clinical Trials - Mayo Clinic Research
This will provide data and material for clinical and translational research to address questions related to the fundamental differences between the spondyloarthropathies and inflammatory arthritis relating to …
RA Research Presented at ACR Convergence 2025 in Focus
Jan 9, 2026 · This synopsis of research into rheumatoid arthritis highlights key areas presented at ACR Convergence 2025, including strategies to delay or prevent RA, emerging mechanisms of action in …
Clinical Trials register - Search for Rheumatoid Arthritis
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
Lynk’s selective JAK inhibitor claims Phase III RA win - Clinical ...
6 days ago · Lynk Pharmaceuticals has posted positive topline results from a Phase III trial on its next generation Janus kinase 1 (JAK1) inhibitor, zemprocitinib, in rheumatoid arthritis (RA). During the …